HAMP and hepatocellular carcinoma: Since p53 can activate HAMP transcription [46], TP53 mutations at the cirrhosis stage may cause HAMP downregulation at this stage, and both TP53 mutations and the downregulated hepcidin may prevail from there onwards up to the HCC stage.